-
Schedule Highlights from the Program Chairs: Monday, April 20
Don’t miss a morning Plenary Session on advances in artificial intelligence, an afternoon address by NCI Director Anthony G. Letai, MD, PhD, FAACR, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.
-
Tuesday Plenary Session will examine population trends and potential drivers of early-onset cancers
The fourth Plenary Session will integrate population trends, etiologic clues, tumor biology, and real‑world outcomes to discuss potential causes and actionable opportunities for prevention.
-
Meet-the-Expert Sessions return to showcase work from leading researchers
On Monday, two cancer research luminaries will discuss strategies for integrating both molecular and digital pathology and work on how neutrophils are reprogrammed on behalf of cancer within the tumor microenvironment.
-
2026 Opening Ceremony showcased a year of sustained progress and landmark AACR initiatives
AACR Chief Executive Officer Margaret Foti, PhD, MD (hc), and other speakers highlighted the impressive work of the AACR and its members, as thousands of enthusiastic researchers from around the world gathered to hear the state of the cancer research union.
-
Schedule Highlights from the Program Chairs: Sunday, April 19
Don’t miss the Opening Ceremony and Opening Plenary, the first New Drugs on the Horizon sessions, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.
-
Monday Plenary Session will examine the transformative potential of AI for cancer research and care
The third Plenary Session will feature speakers who are harnessing the power of artificial intelligence (AI) to augment approaches to complex cancer research.
Meet the 2026 NextGen Stars
